For research and educational purposes only. Not medical advice.
Epithalon Reference
Educational, not medical advice reference for Epithalon: Longevity; regulatory status, evidence posture, source review, and schedule notes. Also known as Epi…
Reference summary
Most evidence is preclinical. Human follow-up publications often involve epithalamin or older Russian geroprotector programs rather than contemporary independent epitalon trials.
- Categories
- Longevity
- Aliases
- Epitalon, AEDG peptide, Epithalamin-related tetrapeptide
- Evidence posture
- translational — Human literature is older, indirect, and not the same as modern vial products.
- Regulatory status
- No FDA-approved Epithalon drug label. FDA lists Epitalon among bulk substances with safety-risk concerns.
- Content review status
- research reference